Biostate AI Closes $12M to Bring the Netflix Model to Molecular Diagnostics

Biostate AI raises USD $12 million to expand RNAseq precision AI

Biostate AI has raised USD $12 million to enhance AI tech for predicting disease progression using RNA sequencing, aiming to advance personalised medicine globally.

Biostate AI closes $12M to bring the Netflix model to molecular diagnostics

The company is reimagining the fragmented reality of molecular research by building the world’s largest RNA sequencing dataset. This dataset will train a general-purpose AI to understand—and eventually guide therapies for—all human diseases. Houston, TX – May 20, 2025 – Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. Additional inv…

Biostate AI Raises $12M Series A to Train the ChatGPT of Molecular Medicine

Biostate AI, a molecular diagnostics startup combining next-generation RNA sequencing (RNAseq) with generative AI, announced today it has raised $12 million in a Series A funding round led by Accel. The round also saw participation from Gaingels, Mana Ventures, InfoEdge Ventures, and returning investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures. High-profile angels such as Anthropic CEO Dario Amodei, 10x Genomics CTO Mi…

Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. Additional investors included Gaingels, Mana Ventures, InfoEdge Ventures, and existing investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures. The company’s seed round also attracted notable angel investors, including Dario Amodei (CEO, Anthropic), Mike Schnall-…

Biostate AI Closes $12M to Bring the Netflix Model to Molecular Diagnostics

Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. Additional investors included Gaingels, Mana Ventures, InfoEdge Ventures, and existing investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures. The company’s seed round also attracted notable angel investors, including Dario Amodei (CEO, Anthropic), Mike Schnall-…

Biostate AI Secures $12M to Optimize RNA Sequencing

What You Should Know:  – Biostate AI, an innovator at the intersection of artificial intelligence and RNA sequencing raises $12M in Series A funding spearheaded by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures, and existing investors Matter Venture Partners, Vision Plus Capital, and Catapult Ventures. This brings the company’s total funding to over $20M. – The newly acquired funds will be pivotal in advancing Biostate…